Inspire Medical Systems, Inc.

NYSE:INSP

Sector

🏥 Health Care

Industries

💻 Telehealth

🧬 Biotechnology

🔬 Clinical Trials

🩺 Medical Instruments

Location

United States

Market Cap

USD 3.86 B

Share Price

USD 130.91

Avg Daily Volume

490,941

Change (1 day)

0.93%

Change (1 year)

-21.94%

Change (YTD)

-29.38%

Inspire Medical Systems, Inc. Revenue for the Trailing 12 Months (TTM) ending March 31, 2025: USD 840.11 M

Inspire Medical Systems, Inc. Revenue is USD 840.11 M for the Trailing 12 Months (TTM) ending March 31, 2025, a 27.11% change year over year. Revenue is the total amount of money generated from the sales of goods or services by a company during a specific period.

Inspire Medical Systems, Inc. Revenue for the Trailing 12 Months (TTM) ending March 31, 2024 was USD 660.91 M, a 41.71% change year over year.
Inspire Medical Systems, Inc. Revenue for the Trailing 12 Months (TTM) ending March 31, 2023 was USD 466.37 M, a 77.72% change year over year.
Inspire Medical Systems, Inc. Revenue for the Trailing 12 Months (TTM) ending March 31, 2022 was USD 262.42 M, a 95.28% change year over year.
Inspire Medical Systems, Inc. Revenue for the Trailing 12 Months (TTM) ending March 31, 2021 was USD 134.39 M, a 54.21% change year over year.

Quarterly
Annual
TTM

From:

To:

Zoom:

Key data

Date	Revenue	Revenue	Gross Profit	Operating Income

NYSE: INSP

Inspire Medical Systems, Inc.

CEO	Mr. Timothy P. Herbert
IPO Date	May 3, 2018
Location	United States
Headquarters	5500 Wayzata Boulevard
Employees	1,246
Sector	🏥 Health Care
Industries Telehealth 🧬 Biotechnology 🔬 Clinical Trials 🩺 Medical Instruments

Description

Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. It also develops a novel, a closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.